Alivexis, Inc.
PrivateLast Round
Series D
Mar 3, 2025
Total Funding Raised
$65.1M
Company Overview
Alivexis, Inc. is a biotechnology company that merges cutting-edge drug discovery platforms with disease biology expertise to develop a portfolio of small molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alivexis, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Alivexis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2025 | ||||
| Series D | Jan 7, 2025 | ||||
| Series C | Mar 1, 2022 | ||||
| Series B | May 13, 2020 | ||||
| Series A | Aug 9, 2018 |
Key People
Founding team and executive leadership
Alivexis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series C, Series B |
| Keio Innovation Initiative | Series C, Series B |
| Mizuho Capital | Series B |
| JIC Venture Growth Investments | Series D |
| Heights Capital Management | Series C |
| Mobile Internet Capital | Series B |
| Fast Track Initiative | Series D, Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 190% MoM, reaching 4.6K.
- Mar 11, 2025
Will present at the GTC 2025 japan AI day event.
Alivexis, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alivexis, Inc.'s valuation, stock price, and market status.